Idiopathic pulmonary fibrosis
Typical setting: A usual interstitial pneumonia pattern develops without an identified secondary cause, typically in older adults.
Aberrant epithelial repair drives patchy subpleural fibrosis, traction bronchiectasis, and honeycomb remodelling.
Connective-tissue disease
Typical setting: Systemic sclerosis, rheumatoid arthritis, inflammatory myopathy, or other autoimmunity affects lung tissue.
Immune injury and repair create inflammatory or fibrotic patterns that may precede obvious systemic features.
Hypersensitivity pneumonitis
Typical setting: Repeated inhalation of avian, mould, agricultural, or occupational antigen sensitises the lung.
Immune inflammation around small airways and alveoli can become fibrotic if exposure persists.
Occupational mineral dust
Typical setting: Silica, asbestos, coal, or other respirable particles accumulate after sufficient exposure.
Macrophage activation and poorly cleared particles promote nodular or diffuse fibrosis and associated malignancy risks.
Drug or radiation injury
Typical setting: Amiodarone, selected anticancer or immune therapies, nitrofurantoin, and thoracic radiation can injure lung.
Direct toxicity or immune inflammation damages alveolar epithelium and may progress to fibrosis.
Sarcoidosis and granulomatous disease
Typical setting: Dysregulated cellular immunity forms non-caseating granulomas in susceptible people.
Granulomatous inflammation follows lymphatic distributions and can resolve or leave fibrotic distortion.